Compare RDY & WYNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RDY | WYNN |
|---|---|---|
| Founded | 1984 | 2002 |
| Country | India | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Hotels/Resorts |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.6B | 10.7B |
| IPO Year | 2001 | 2002 |
| Metric | RDY | WYNN |
|---|---|---|
| Price | $13.84 | $99.40 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 14 |
| Target Price | $16.90 | ★ $144.43 |
| AVG Volume (30 Days) | 1.8M | ★ 1.8M |
| Earning Date | 05-08-2026 | 05-05-2026 |
| Dividend Yield | 0.51% | ★ 0.97% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 3.14 |
| Revenue | N/A | ★ $6,717,660,000.00 |
| Revenue This Year | $7.50 | $6.35 |
| Revenue Next Year | $2.96 | $4.58 |
| P/E Ratio | ★ $18.67 | $32.87 |
| Revenue Growth | N/A | ★ 10.67 |
| 52 Week Low | $12.26 | $65.25 |
| 52 Week High | $16.17 | $134.72 |
| Indicator | RDY | WYNN |
|---|---|---|
| Relative Strength Index (RSI) | 40.69 | 39.58 |
| Support Level | $12.97 | $96.37 |
| Resistance Level | $14.14 | $111.94 |
| Average True Range (ATR) | 0.24 | 3.30 |
| MACD | -0.08 | 0.22 |
| Stochastic Oscillator | 3.55 | 36.59 |
Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.
Wynn Resorts operates luxury casinos and resorts. The company was founded in 2002 by Steve Wynn, the former CEO. The company operates four mega resorts: Wynn Macau and Encore in Macao and Wynn Las Vegas and Encore in Las Vegas. Cotai Palace opened in August 2016 in Macao, and Encore Boston Harbor in Massachusetts opened June 2019. We expect the company to continue to build nongaming attractions in Macao over the next few years. We model Wynn's managed integrated resort in the United Arab Emirates to open in 2027. The company also operates Wynn Interactive, a digital sports betting and iGaming platform, in a few states. The company received 76% and 24% of its 2019 prepandemic EBITDA from Macao and the US, respectively. In 2024, both the US and Macao were each 50% of total EBITDA.